↓ Skip to main content

Toward Development of iMesenchymal Stem Cells for Immunomodulatory Therapy

Overview of attention for article published in Frontiers in immunology, January 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

blogs
1 blog
twitter
2 X users

Citations

dimensions_citation
82 Dimensions

Readers on

mendeley
110 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Toward Development of iMesenchymal Stem Cells for Immunomodulatory Therapy
Published in
Frontiers in immunology, January 2016
DOI 10.3389/fimmu.2015.00648
Pubmed ID
Authors

Samantha F. H. de Witte, Marcella Franquesa, Carla C. Baan, Martin J. Hoogduijn

Abstract

Mesenchymal stem cells (MSC) are under development as an immunomodulatory therapy. The anticipated immunomodulatory effects of MSC are broad, from direct inhibition of lymphocyte proliferation, induction of regulatory T and B cells, to resetting the immune system via a hit-and-run principle. There are endless flavors of MSC. Differences between MSC are originating from donors variation, differences in tissue of origin, the effects of culture conditions, and expansion time. Even standard culture conditions change the properties of MSC dramatically and generate MSC that only remotely resemble their in vivo counterparts. Adjustments in culture protocols can further emphasize properties of interest in MSC, thereby generating cells fitted for specific purposes. Culture improved immunomodulatory MSC can be designed to target particular immune disorders. In this review, we describe the observed and the desired immunomodulatory effects of MSC and propose approaches how MSC with optimal immunomodulatory properties can be developed.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 110 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Germany 1 <1%
Unknown 108 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 20 18%
Researcher 20 18%
Student > Master 16 15%
Student > Bachelor 15 14%
Other 7 6%
Other 10 9%
Unknown 22 20%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 21 19%
Agricultural and Biological Sciences 20 18%
Veterinary Science and Veterinary Medicine 11 10%
Medicine and Dentistry 11 10%
Engineering 6 5%
Other 15 14%
Unknown 26 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 January 2016.
All research outputs
#4,351,115
of 25,932,719 outputs
Outputs from Frontiers in immunology
#4,767
of 32,608 outputs
Outputs of similar age
#67,443
of 402,523 outputs
Outputs of similar age from Frontiers in immunology
#25
of 133 outputs
Altmetric has tracked 25,932,719 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,608 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 402,523 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 133 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.